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Abstract
Background: The Time Trade-Off (TTO) is a widely used instrument for valuing preference-based health-related
quality of life (HRQoL). The TTO reveals preferences for own current health (‘utilities’) on a scale anchored between
death (0) and perfect health (1). Limited information on the external validity of the TTO is available. Aim of this pilot
study was to examine the construct validity of both an interview TTO and a computer-based TTO in patients with
rheumatoid arthritis (RA).
Methods: Thirty patients visiting the outpatient rheumatology clinic participated. Construct validity was assessed by
measuring convergent and discriminative validity. Convergent validity was assessed by calculating Spearman’s
correlations between the utilities obtained from the TTOs and pain, general health (rating scales), health-related
quality of life (SF-36 and SF-6D) and functional status (HAQ-DI). Discriminative power of both TTO measures was
determined by comparing median utilities between worse and better health outcomes.
Results: Correlations of both TTO measures with HRQoL, general health, pain and functional status were poor
(absolute values ranging from .05 to .26). Both TTOs appeared to have no discriminative value among groups of RA
patients who had a worse or better health status defined by six health outcome measures. About one-third of
respondents were zero-traders on each of the TTO measures. After excluding zero-traders from analysis, the
correlations improved considerably.
Conclusions: Both the interview TTO and computer TTO showed poor construct validity in RA patients when using
measures of HRQol, general health, pain and functional status as reference measures. Possibly, the validity of the
TTO improves when using an anchor that is more realistic to RA patients than the anchor ‘death’.
Background
The Time Trade-Off (TTO) [1] is an instrument devel-
oped to assess effects of treatments in cost-utility ana-
lyses (CUAs) by measuring changes in health-related
quality of life (HRQoL) directly by patients. The TTO
reveals preferences for own current health (‘utilities’) on
a scale anchored between death (0) and perfect health
(1) by asking people how many life years they are willing
to give up to become perfectly healthy. It is assumed
that the more life years people are willing to trade off,
the worse their health state is. The purpose of this meas-
ure is to capture the desirability of patients’ own health
state reflecting their health-related quality of life
(HRQoL).
Traditionally, the TTO is administered by interview.
The TTO can also be administered by questionnaire or
computer. Furthermore, different methodological
approaches to the TTO are used [2]. This makes com-
parison between studies difficult. Differences in TTO
procedures seem to influence utilities. For example, it
has been found that utility scores are heavily influenced
by the method of elicitation (ping-pong, titration) [3].
Furthermore, the mode of administration (interview/
computer/questionnaire) or the way the TTO question
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is formulated can influence utilities. Besides, the size of
time frame that is used (e.g. fixed time period, life ex-
pectancy) has a great impact, since utilities are calcu-
lated as the proportion of the remaining lifetime
sacrificed [2].
Few studies have examined psychometric properties
of the interview TTO in rheumatoid arthritis (RA). The
studies that reported on the construct validity, showed
poor to moderate correlations between TTO and mea-
sures of HRQoL, functional status, disease activity and
pain [4-6]. It was found that the TTO was only able to
discriminate between worse or better disease-specific
HRQoL using the RAQoL [4,5], between worse or bet-
ter outcomes on the dimensions ‘symptom’ and ‘role’ of
the disease-specific AIMS-2 [5] and between worse or
better mental health using the RAND-36 mental com-
ponent summary scale [4]. Tijhuis et al. showed that
the TTO was able to discriminate between worse or
better pain, worse or better disease activity and worse
or better functional status [4]. In contrast, Bejia et al.
showed that the TTO was not able to discriminate be-
tween worse and better pain or worse and better dis-
ease activity [5].
Computer-based utility elicitation procedures to adminis-
ter the TTO have been developed, for example iMPACT3
[7] and U-Titer [8]. Studies in a range of conditions have
used such computer-based programmes to administer a
TTO using different procedures [7,9].
In this study, we report on preliminary results with re-
spect to the construct validity of the TTO assessed in
patients with RA using an interview TTO as well as a
computer TTO, and using a standardised procedure for
both TTOs. The first aim of this study was to examine
convergent validity of the interview and computer TTO
separately by correlating TTO utilities of both TTO
measures with other patient-reported outcomes (PROs)
in patients with RA. The second aim was to examine
whether the interview and computer TTO were able to
discriminate between worse and better patient-reported
health outcomes.
Methods
Patients and study design
Thirty consecutive outpatients (aged 18–85) of our
rheumatology clinic who were diagnosed with RA parti-
cipated. People who did not understand the Dutch lan-
guage were excluded.
All participants completed the TTO twice with an
interval of 14 days. Randomly the first TTO was either
interview or computer-based, consequently followed by
the other at the next assessment. Measures of pain,
general health, health-related quality of life and func-
tional status were administered at the first TTO as-
sessment. Informed consent was obtained from all
participants. According to legislation in the Nether-
lands (WMO), no approval of the ethical review board
was indicated.
Measures
TTO interview
The Time Trade-Off question used in this study was for-
mulated as follows:
“Imagine that a new treatment became available which
helped you to recover fully. A side-effect of this treat-
ment, however, is that you will die sooner. Would you
opt for this treatment?” A graphical aid was used to
make the question more clearly. When participants
asked about the definition of being perfectly healthy,
they were told to imagine being in perfect health without
any disease or health-related complaints.
A life time perspective was adopted. Life expectancy
calculations of the Dutch Central Bureau of Statistics
[10] were used. The remaining life expectancy was cal-
culated by extracting the age of the participant from
his or her expected age of dying according to the CBS.
The bisection method was applied to reach the point
at which participants did not prefer one of the two
options: staying in their health state for the rest of
their lives or being perfectly healthy for a shorter life
time. Therefore, the trade-off started with setting the
shorter life in perfect health on half of the remaining
life expectancy. For example, a person with a re-
maining life expectancy of 20 years was first asked
about his or her willingness to trade off 10 life years.
If the person accepted the trade, a remaining life ex-
pectancy of five years in perfect health was presented.
If the person did not accept the trade, a remaining life
expectancy of 15 years was presented. This process
continued until the patient was indifferent between his
or her own current health state according to his or
her life expectancy and a shorter life in perfect health.
Then, the TTO score was calculated by the formula:
1-(number of life years given up/remaining expected
life years).
Computer TTO
Utilities were obtained by means of touch screens.
Graphical presentations supported the TTO question
(Figure 1). The computer TTO and the interview TTO
were formatted equally, using similar formulations and
graphical presentations. The bisection method was used
to find the indifference point. During the computer as-
sessment of the TTO, the researcher (LB) was present to
start up the computer. The respondents completed the
TTO independently. The researcher observed the
patients during the assessment. Our previous study [11]
demonstrated that the test retest-reliability of this
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computer TTO was good (ICC= 0.88) and comparable
with the test reliability of the interview TTO [4,5].
NRS pain and general health
Current severity of pain and current general health were
both measured by a numerical rating scale (NRS), ran-
ging from 0 (best) to 10 (worst).
SF-36
Physical and mental health were measured by calculating
the physical and mental component summary scores
(PCS and MCS) of the SF-36 version 2 [12], a generic
descriptive instrument for measuring health-related
quality life on eight dimensions (mental functioning,
physical functioning, bodily pain, vitality, role limitations
due to physical problems, role limitations due to emo-
tional problems, social functioning and general health).
The scores range from 0 to 100, whereby a higher score
indicates a better health.
SF-6D
From the SF-36, SF-6D utility scores were derived,
reflecting health state valuations of the general public
[13]. The utility scores range from 0 to 1, whereby a
higher score indicates a better HRQoL.
HAQ-DI
The level of functional disability was assessed by the
Health Assessment Questionnaire Disability Index
(HAQ-DI) [14], a self-report measure consisting of eight
categories (dressing and grooming, arising, eating, walk-
ing, hygiene, reach, grip and common daily activities).
The HAQ score ranges from 0 to 3, whereby a higher
score indicates a worse functional status.
Figure 1 Two screen shots of the computer TTO*. Here, a person with a life expectancy of 27 years was asked about his or her willingness to
trade off 13 life years. The person did not accept the 13 years in perfect health, so six years were added in the second question. *for this
publication the screen shots were translated from Dutch to English.
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Statistical analysis
To examine the presence of an order effect between par-
ticipants who started with the interview TTO or with
the computer TTO, a Mann–Whitney U-test was
performed.
Construct validity was assessed by measuring conver-
gent and discriminative validity. Convergent validity of
the interview and computer version was assessed by cal-
culating Spearman’s correlations between each of the
TTOs with the NRS for pain and general health, SF-36,
SF-6D and HAQ-DI. Moderate correlations (0.40-0.59)
are expected: all measures (except for the SF-6D) are de-
scriptive, and most instruments only capture one or
some aspects of the construct quality of life. The SF-6D
yields utilities, but these are derived from a general pub-
lic. A sample of 29 participants is required to demon-
strate a significant moderate Spearman’s correlation of
0.50 with an alpha of 0.05 (one-tailed) and a power (1-β)
of 0.80. Discriminative power of the interview TTO and
computer TTO was determined by comparing median
utilities between worse and better pain, general health,
HRQoL and functional status. Therefore, the outcome
measures were dichotomised by the median score. A
worse health outcome was defined by the ≤median value
of the outcome measure. A better health outcome was
defined by the>median value of the outcome measure.
Because of a difference in scaling of the NRS (Pain and
General Health) and HAQ-DI, a worse health outcome
on these instruments was defined by the > median value
of the outcome measure. A better health outcome was
defined by the ≤ median value of the outcome meas-
ure. The Mann–Whitney U-test was used to test sig-
nificance. Data were analysed using SPSS version
16.0.
Results
Subjects
All 30 patients who participated completed both TTO
measures. Demographic, clinical and psychosocial char-
acteristics and utility scores for both TTO methods of
the 30 patients are shown in Table 1. Median TTO utility
scores were 0.87 (interview TTO) and 0.85 (computer
TTO). Ten participants did not want to trade any life
year for perfect health on the interview TTO; eight parti-
cipants did not want to trade any life year for perfect
health on the computer TTO (zero-traders). Zero-
traders did not have a significantly different self-reported
health than traders (data not shown). Six zero-traders on
the computer TTO were also zero-traders on the inter-
view TTO. Two zero-traders on the computer TTO were
not zero-traders on the interview TTO, and two zero-
traders on the interview TTO were not zero-traders on
the computer TTO.
Test order
For neither interview TTO utility scores nor computer
TTO utility scores an effect of test order was found
(P = 0.37 and P = 0.73 respectively). So, no significant dif-
ferences in utility scores existed between patients who
started with the interview TTO or computer TTO.
Construct validity: Convergent and discriminative validity
Correlations between utilities and scores on rating scales
for pain and general health, SF-36, SF-6D and HAQ-DI
are shown in Table 2. In the entire group of RA patients,
poor correlations were found between either both TTOs
and the NRS measuring pain and general health, phys-
ical and mental component summaries of the SF-36, the
SF-6D and the HAQ-DI. After exclusion of zero-traders,
the correlations were moderate and significant between
Table 1 Demographic, clinical and psychosocial
characteristics
N (30)
Age (mean years ± SD) 58 ± 13
Gender (%)
Men 27
Women 73
Disease duration (median years (IQR)) 10 (19–3)
Marital status (%)
Single 17
Married/Living together 83
Educational level (%)
Low 50
Moderate 30
High 20
Work status (%)
Paid work 40
Housekeeping 10
retired/unemployed/disabled 50
Utilities (Median (IQR))
Interview TTO 0.87 (0.80-0.87)
Computer TTO 0.85 (0.58-0.85)
Pain (numerical rating scale)
(median (IQR))
4 (2–6)
General Health (numerical rating scale)
(median (IQR))
5 (3–6)
Descriptive health-related
quality of life (SF36) (median (IQR))
Physical 40.05 (34.22-46.73)
Mental 40.99 (35.68-43.95)
Preference-based health related
quality of life (SF-6D) (median (IQR))
0.63 (0.59-0.75)
Functional status (HAQ-DI) (median (IQR)) 0.88 (0.34-1.38)
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either the interview TTO and the NRS measuring pain
(r =−0.38) and general health (r =−0.42), the physical
component summary of the SF-36 (r = 0.45), and the SF-
6D (r = 0.45). In addition, moderate and significant cor-
relations were found between either the computer TTO
and the NRS pain (r =−0.47) and the HAQ-DI
(r =−0.38) (Table 2). All other correlations remained
non-significant after exclusion of zero-traders. Discrim-
inative properties of both TTOs are shown in Table 3.
Both TTOs proved to have no discriminative value be-
tween worse and better health outcomes for all six out-
come measures. Performing these analyses without the
zero-traders resulted in larger and significant median
differences in interview TTO scores between worse and
better outcomes for the physical component summary of
the SF-36 (difference in mean rank = 5.50), the NRS
measuring pain (difference in mean rank = 5.83) and the
SF-6D (difference in mean rank = 4.85). In addition, lar-
ger and significant median differences in computer TTO
scores between worse and better outcomes were found
for the NRS measuring pain (difference in mean rank =
6.30). No significant median differences in TTO scores
between worse and better health outcomes were found
for the other outcome measures.
Discussion
This pilot study showed that the construct validity of
both the interview TTO and computer TTO was poor
in patients with RA when using measures of HRQol,
general health, pain and functional status as reference
measures. After exclusion of zero-traders from analysis,
the results improved. This finding was expected, because
zero-traders did not have a significantly different health
status compared with traders. Indications of the poor
convergent validity of the TTO were also found in other
studies in RA and studies in other diseases [4-6,9,15-17].
In most of these studies it was unclear how many parti-
cipants were zero-traders and whether they were in- or
excluded. One study reported similar results when in- or
excluding zero-traders from analysis [15]. In our study,
we did not find the TTO to be discriminative for any of
the health outcome measures used. Other studies found
evidence for and against its discriminative ability
[4,5,9,16]. Contradicting findings were found for pain
and disease activity scores in patients with RA [4,5] and
for functional status scores in patients with cardiovascu-
lar disease [9,16].
All these studies were found to have differences in the
TTO procedure applied. This might explain the
Table 2 Spearman’s correlations (95% confidence intervals) of interview TTO or computer TTO utilities with health
outcome measures for the total sample and for the traders only
Interview TTO Interview TTO traders only Computer TTO Computer TTO traders only
(N= 30) (N= 20) (N = 30) (N= 22)
Pain (NRS) −0.10 (−0.45, 0.27) −0.38 (−0.70, 0.08)* −0.26 (−0.57, 0.11) −0.47 (−0.74, -0.05)*
General Health (NRS) −0.08 (−0.43, 0.29) −0.42 (−0.73, 0.03)* −0.05 (−0.40, 0.32) −0.13 (−0.53, 0.30)
Descriptive HRQoL (SF-36)
PCS 0.16 (−0.22, 0.49) 0.45 (0.01, 0.74)* 0.22 (−0.15, 0.54) 0.35 (−0.08, 0.67)
MCS 0.24 (−0.14, 0.55) 0.32 (−0.14, 0.67) 0.22 (−0.15, 0.54) 0.24 (−0.20, 0.60)
Preference-based HRQoL (SF-6D) 0.18 (−0.21, 0.50) 0.45 (−0.01, 0.73)* 0.11 (−0.27, 0.45) 0.20 (−0.24, 0.57)
Functional status (HAQ-DI) −0.07 (−0.42, 0.29) −0.20 (−0.59, 0.27) −0.21 (−0.53, 0.17) −0.38 (−0.69, 0.05)*
NRS = numerical rating scale; HRQoL = health-related quality of life; PCS = Physical Component Summary; MCS =Mental Component Summary.
 Negative correlations were caused by a difference in scaling between the TTO and three health outcomes: a higher TTO score means a better HRQoL,
whereas a higher score on these health outcomes means a worse health outcome.
*Significant correlations (P< 0.05).
Table 3 Discrimination of the interview and computer TTO between worse and better health outcomesa d
Interview TTO utilities (N= 30) Computer TTO utilities (N= 30)
Worse health outcomesb c Better health outcomes P Worse health outcomesb c Better health outcomes P
Pain (NRS)e 0.87 (0.81-0.97) 0.87 (0.57-1.00) 0.48 0.60 (0.50-1.00) 0.85 (0.74-0.97) 0.15
General Health (NRS) 0.87 (0.79-0.99) 0.93 (0.77-1.00) 0.31 0.87 (0.58-1.00) 0.82 (0.57-0.98) 0.23
SF-36 PCS 0.86 (0.67-1.00) 0.88 (0.80 -1.00) 0.24 0.77 (0.53-1.00) 0.85 (0.71-1.00) 0.26
PCS 0.87 (0.63-1.00) 0.87 (0.80 -1.00) 0.45 0.84 (0.50-1.00) 0.85 (0.60-1.00) 0.28
SF-6D 0.87 (0.79-1.00) 0.88 (0.78-0.96) 0.36 0.86 (0.58-1.00) 0.81 (0.58-0.95) 0.29
HAQ-DI 0.91 (0.82-1.00) 0.85 (0.70-0.99) 0.48 0.86 (0.52-1.00) 0.85 (0.59-0.92) 0.37
a Utilities are expressed in median scores (interquartile range); b For NRS (Pain), NRS (General Health) and HAQ-DI: a worse health outcome was defined by
the>median value of each outcome measure; c For the SF-36 and SF-6D: a worse health outcome was defined by the≤median value of each outcome measure;
d Median values for the NRS (Pain), 4; for the NRS (General health), 5; for the SF-36 PCS, 40.05, MCS, 40.99; for the SF-6D, 0.63; for the HAQ-DI, 0.88;
e NRS = numerical rating scale.
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contradicting results regarding the discriminative ability
of the TTO. Beside the mode of administration, studies
differed in the time frame used (remaining life expect-
ancy [4,5,16-18], time frame dependent on age group [6]
or not mentioned [15]). Furthermore, some studies
described the way in which people had to think about
current health [16,17] and/or about the anchors perfect
health [4,5,16] and death [16], whereas other studies did
not [6,9,18]. One study used a symptom-free anchor (‘no
angina’) instead of ‘perfect health’ [9]. In many studies it
was stated that a visual aid was used, although no fur-
ther information was given about its representation
[4-6]. Besides, many studies did not report the precise
method of elicitation (e.g. ping-pong) [4-6,9,18].
In our study, the TTO procedure applied was precisely
described, facilitating the comparison with other studies.
Strengths of this study were the fact that we used two
different TTO assessments and that we used a broad set
of PROs in a homogeneous population consisting of RA
patients. A limitation of this study was the use of a small
convenience sample.
There are several explanations possible for the results
of our study, irrespective of the TTO procedure used.
First, the low correlation with the SF-6D, another
preference-based instrument, can be partly explained by
the difference in perspective used to obtain utilities. SF-
6D utilities are derived from the general public, so these
scores represent a societal perspective. TTO scores were
directly calculated from the patients’ preferences, repre-
senting a patient perspective. Secondly, except for the
SF-36 and SF-6D, the comparators used in this study
only measure one aspect (e.g. functional status) of the
construct quality of life. Furthermore, except for the
SF-6D, the comparators are descriptive which implies
that valuations of health states are not assessed. With
these measures patients are asked about their levels of
impaired health or pain, whereas personal preferences
toward their health state remain unrevealed. It is pos-
sible that people with the same health state report dif-
ferent utilities if they have different ‘aspirations’ [18].
Nease et al. illustrate this by the example that inability
to walk ‘more than a city block’ does not have to be a
limitation if someone does not desire to be active [18].
Therefore, it would be worthwhile to examine in fu-
ture studies whether it is better to validate the TTO
against individualized measures of personal preferences,
such as the SEIQOL [19,20] or MACTAR [21].
Thirdly, it has been found that preferences are prone
to biases inherently to the nature of the TTO, such as
loss aversion. Loss aversion can be observed when a
choice has to be made between ‘remaining the status
quo’ (remaining in the current health state) and
‘accepting an alternative to it’ (trading off life years for
perfect health). In that case people will evaluate the
advantages and disadvantages of the alternative in
terms of losses and gains [22]. The TTO asks people
about their willingness to trade off life years (a loss)
for optimal health (a gain) [23]. Because ‘losses loom
larger than gains’ [22], people become reluctant to give
up life years. This will result in higher utilities, as sup-
ported by findings of Van Osch et al. [24]. Further-
more, TTO utilities might be influenced by other
factors that are unrelated to current health [15], such
as family-related aspects, for example having children
[2] or seeing grandchildren grow up [17]. Finally, the
nature of the disease can influence utilities. Asking
patients to trade off life years may feel unrealistic, be-
cause patients with RA do not perceive their disease
as life-threatening [6]. Therefore, people may be less
willing or not willing at all to trade off life years. Our
results are indicative of this: irrespective of health, a
relatively large number of participants were not willing
to trade any life year for perfect health. For chronic
illnesses such as RA there may be more realistic
health-related anchors, for example ‘becoming
dependent on others’ and ‘having increased physical
limitations’, which were reported by RA patients to
worry them [25,26]. It could be examined whether the
validity of the TTO improves when changing the
trade-off about dying earlier in other more realistic
(health-related) trade-offs. The use of a ‘chained’ TTO
procedure could also improve the validity of the TTO.
In a chained procedure, the health state of interest is
not directly compared with death but indirectly with
the aid of an intermediate anchor health state [27-29].
A limitation is that a chained procedure is more com-
plex, because it adds an additional step to the valu-
ation process, possibly leading to extra noise [28].
Limited research has been performed on the chained
TTO and has been mainly applied in temporary health
states [28-30]. For chronic health states it has been
shown that chained TTOs are systematically biased
upwards (when the worst endpoint was varied) or
downwards (when the best endpoint was varied), but
that it is possible to correct for these biases [31].
However, the respondents were not patients, but
healthy people and women at high risk for breast can-
cer. Research in chronically ill patients examining the
validity of the chained TTO for chronic states is
lacking.
Conclusions
In conclusion, both the standardised interview TTO and
standardised computer TTO showed similar poor results
regarding construct validity when using measures of
HRQoL, general health, pain and functional status as
reference measures. Possibly, the validity of the TTO
can be improved by replacing the anchor ‘death’ by an
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anchor that is more realistic to RA patients. Future stud-
ies in which direct patient reported utilities are derived,
could start with the development of a TTO instrument
using realistic anchors for RA patients. This instrument
could be validated against individualized measures of
personal preferences, such as the SEIQOL or MACTAR
instrument.
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